BioSpace News Archive

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating cancer patients, announces results from a prospective study comparing its Target Selector™ cerebrospinal fluid testing to conventional cytology in patients with non-small cell lung cancer (NSCLC) and leptomeningeal metastasis

OncoHost, a global leader in host response profiling for improved personalized cancer therapy, announced today that Professor Yuval Shaked, co-founder and Chief Scientific Advisor at OncoHost, and Professor of Cell Biology and Cancer Science at the Technion – Israel Institute of Technology,

Thailand, with a Population of 70 million People, Joins Other Significant Territories Japan and Singapore That will Benefit From IceCure’s Cryoablation Products

Fresenius Kidney Care , the dialysis services division of Fresenius Medical Care North America and the nation’s leading network of dialysis facilities, is deploying CommonWell health data exchang

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter of 2020 before the market opens on Wednesday, October 21, 2020 , and will hold a conference call on the same day at 8:30 a.m. EDT . During the call, the company will discuss

With rising numbers of Americans testing positive for COVID-19, including President Trump, the COLCORONA trial adds enrollment sites in the United States and including locations in Mississippi, Arizona, Minnesota, South Carolina, North Carolina and Florida.

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced the appointment of Mike Ouimette as general counsel and corporate secretary of the company.

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced the Company has been accepted to present its pivotal cellulite data via an online poster during the Virtual American Society for Dermatologic Surgery (ASDS) 2020 Annual Meeting, ta

Crown Laboratories announced today that it has launched PanOxyl PM Overnight Spot Patches, an advanced overnight blemish removing technology

UroGen Pharma Ltd. announced that, on October 1, 2020, the Compensation Committee of its Board of Directors granted inducement stock options to purchase up to an aggregate of 170,000 ordinary shares and 70,700 restricted stock units to eight new employees in connection with their employment with UroGen.